The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapy
Kazunori Yokomine(Kumamoto University), Yasuharu Nishimura(Kumamoto University), Yataro Daigo(The University of Tokyo), Hirotaka Iwase(Kumamoto City Hospital), Yutaka Sasaki(Iwate Medical University), Satoru Senju(Kumamoto University), Yuki Hayashida, Katsunori Imai(Kumamoto University), Tetsuya Nakatsura(Unknown), Hiroaki Nomori(Kashiwa Municipal Hospital), Hideo Baba(Kaketsuken (Japan)), Yusuke Nakamura(Yokohama University of Pharmacy), Koji Takahashi(The University of Tokyo), Atsushi Irie(Kumamoto University), Takuya Tsunoda(Tokyo University of Science), Yoshiaki Ikuta(Kumamoto University), Michiko Harao(Kumamoto University)
Cited by 40
Related Papers
Allelotype of Colorectal Carcinomas
|Science|1989|1.3k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593